The molecular mechanism associated with remission of primary gastric lymphoma post helicobacter pylori eradication is still unclear.
Introduction
Non-Hodgkin's Lymphoma of the stomach is the most common group of primary extra-nodal lymphomas [1] . Primary gastric lymphoma represents 5% of gastric malignancy and shows increasing incidence worldwide [2] . The majority of primary gastric lymphoma are of a B-cell type, representing either as a low-grade disease of Mucosa-Associated Lymphoid Tissue (MALT) subtype or as a more aggressive Diffuse Large B-Cell Lymphoma (DLBCL) [3] , the diffuse lymphoma can arise as a de novo tumor or through transformation from a low grade MALT (MALTDLBCL) [4] .
Helicobacter Pylori infection is known to be linked to the development of MALT of the stomach [5] . It triggers a chronic antigenic stimulus that would initiate the development of gastric MALT along a continuum pathway, and ultimately might lead to a high-grade tumor, this acquires an autonomous growth potential through progressive accumulation of genetic changes [6, 10, 11] . Helicobacter pylori positive infection is observed in 35% of DLBCL of stomach but is found more commonly in cases with concomitant MALT areas than in de novo [7, 8, 12] Eradication of Helicobacter pylori is a well-recognized initial approach to treatment of low-grade gastric MALT lymphomas.
Several studies have shown that Helicobacter pylori eradication lead to a durable histological complete remission in patients with gastric DLBCL (with and without MALT Component) [9] [10] [11] [12] [13] [14] [15] [16] . The molecular mechanism of regression of primary gastric lymphoma after helicobacter pylori eradication is still unknown.
Certain genetic aberration were found to be associated with gastric MALT lymphoma including trisomy 3, trisomy 5, trisomy 18, t [11, 18] (q21,q21) as well as mutation in p53 and p16 which are linked to DLBCL [3, 17, 18] .
Microsatellites are short repeat sequences dispersed throughout the genome. Defects in the DNA repair are reflected by DNA microsatellite instability [18] . Microsatellite instability is used to identify genetic loci that have been lost to detect genomic alterations and to evaluate the contribution of the mutator pathway to the gastric lymphoma pathogenesis [3, 18] . The involvement of microsatellite instability in the pathogenesis of gastric lymphoma is controversial [17, [19] [20] [21] . Many reports have demonstrated that microsatellite instability has more prominent role in the pathogenesis of gastric MALT lymphoma when microsatellite instability analyzed with markers adjacent to chromosomal loci that are involved in lymphomas, 'Real Common Target genes theory' [3, 18] .
We aimed in this study to evaluate Microsatellite instability (MSI) at microsatellite markers adjacent to loci involved in primary gastric lymphoma in relation to helicobacter eradication therapy.
Materials and Methods
One hundred-seven (107) patients with B-cell primary extra-nodal gastric Non-Hodgkin lymphoma were included in this study. None of them had received chemotherapy therapy or H pylori eradication before enrollment to this study, all of them had a negative family history suggestive of hereditary non-polyposis colorectal cancer. Written informed consent was obtained from patients before being interviewed for this study. The diagnosis was established according to the criteria of the WHO Classification by morphological and immunophenotypic analyses [4] .
Staging work-up included detailed The diagnostic work-up included patients' history and physical examination, routine laboratory investigations (such as lactate dehydrogenase [upper range, 240 U/L], liver enzymes, alkaline phosphatase, creatinine, serum protein electrophoresis, immune globulins, and RBCs and WBCs count), chest x-ray, radiologic and endoscopic evaluation with multiple biopsies of the upper and lower GI tract, computed tomography of chest and abdomen and pelvis, bone marrow aspiration & biopsy, and an examination of Waldeyer's ring, small-bowel series, barium enema study of the colon and rectum, and biopsy. Patients were staged according to Musshoff's modification of the Ann Arbor staging system [22] . All patients were positive for Helicobacter pylori, as assessed by rapid urease test, bacterial culture and Warthin-Starry silver staining of gastric biopsy specimens (four biopsy specimens obtained to assess H. pylori infection, two from the greater curvature of the antrum and the others from the greater curvature of the corpus. H. pylori status was determined to be present by a positive result of both Warthin-Starry staining and H. pylori culture).
All patients consented to a Helicobacter Pylori eradication therapy consisted of amoxicillin 500 mg qid, clarithromycin 500 mg bid, plus omeprazole 20 mg bid for 2 weeks.
Patients were scheduled for first follow-up upper gastrointestinal endoscopic examination 4 weeks after completion of antimicrobial therapy, and follow-up repeated every 6 weeks until histological evidence of remission achieved. Complete histological remission was defined according to Wotherspoon's score of 2 or less on every histological section of the biopsy specimens [23] . In patients with grossly stable or progressive disease on follow-up endoscopic examination and in patients with a persistent or increasing proportion of large cells on microscopic examination, was referred immediately to systemic chemotherapy (CHOP). Patients received 2 cycles after achieving CR, minimum 6 cycles in total.
Genomic DNA extraction
Specimens were fixed in 10% formalin and embedded in paraffin wax, and 4-m consecutive sections were used for histological examination by H&E staining. From the paraffin embedded blocks, two 7-m tissue sections were cut. DNA was extracted from the malignant lymphoma area and from normal mucosa of the stomach. The DNA extraction procedure, tissue was precisely microdissected under microscopic visualization using a PixCell-II Laser Capture Microdissection System to avoid DNA contamination of inflammatory or stromal cell nuclei, as previously reported [24, 25] .
Microsatellite marker analysis
As reported previously, microsatellite instability analyzed with micro satellite markers adjacent to chromosomal loci that are involved in lymphomas [3, 18] as follows: D3S1530 (3q27), D5S346 (5q21), D9S171 (9p21), D17S250 (17p12), D18S474 (18q21). One primer for each primer pair was fluorescence-labeled at the 5' end ( FAM, TAMARA, NED, ROX and HEX). Multiplex PCR amplification was carried out in a reaction volume of 10 L, which contained 100 ng of genomic DNA, 1X PCR buffer (Perkin Elmer Applied Biosystems Division, Foster City, CA), 200 mol/L of each dNTP, 600 mol/L of each primer, and 1.5 units of AmpliTaq GOLD polymerase (Perkin Elmer). The MgCl 2 concentration was 1.5 mmol/L. The following PCR cycle conditions were used for amplification: 95°C for 10 min, 30 cycles of 95°C for 45 sec, 55°C for 1 min and 72°C for 30 sec. PCR products were evaluated for MSI by capillary electrophoresis using an ABI prism 310 Genetic analyzer (Perkin Elmer) and automatic sizing of the alleles using a Gene Scan (Applied Biosystems).
Microsatellite instability was defined as a change of length due to either insertion or deletion of repeating units in a microsatellite within tumor cells as compared to normal cells [26, 27] . The change presented as novel peaks in tumor tissue differing in size and location from normal tissue DNA ( Figure 1 ) Tumors defined microsatellite instable when observed in more than 30% of examined loci [26, 27] . In the literature, the MSI phenotype categorized into two groups: MSI-H and MSI-L/MSS, and a sample is defined as MSI only when MSI-H was observed.
Statistical analysis
Comparison of discrete variables was performed by chi-square test or Fisher's exact test. All statistical tests were two-sided, and a P value of less than .05 considered statistically significant. In patients with low-grade MALT lymphoma, the age ranged between 38 and 85 years (mean 59 years), in those with high-grade DLBCL (MALTDLBCL) lymphomas the age range was 45-77 years (mean 60.7 years), and those with de novo DLBCL the range was between 44 and 85 years (mean 67.4 years). A higher mean value of age was found in patients with de novo DLBCL. This finding was found to be statistically significant at analysis compared to low grade cases (P<0.05). There was a predominance of females in the low grade MALT lymphoma group (male/female ratio, 1:2), whereas males predominated among patients with high-grade DLBCL lymphoma (male/female ratio 2.5:1) and the de novo DLBCL patients (male/ female ratio 3:1). The sex ratio of MALT lymphoma patients was statistically significantly different when compared to MALTDLBCL lymphoma patients and de novo DLBCL lymphoma (P<0.001, P0.005) respectively. Analysis of tumor site and endoscopic features showed no significant difference among the 3 groups.
Results
Histopathological examination of the biopsy specimens showed that the disease was confined to the mucosal and submucosal layers in 27 out of 30 patients (90%) in the low-grade MALT lymphomas, 23 out of 36 (64%) in MALTDLBCL lymphomas and 15 out of 41(37%) in de novo DLBCL groups, the incidence was statistically significantly higher in low grade MALT lymphoma in comparison to MALTDLBCL and those with de novo DLBCL (P<0.05,p<0.001 respectively). In contrast, the lymphoma cells invaded the muscular layer or beyond in 26 of 41 (63%) of de novo DLBCL cases. The depth of tumor invasion was significantly greater in de novo DLBCL patients than in those with low grade MALT and MALTDLBCL lymphoma patients (P<0.001, P<0.05 respectively). Table 1 shows the demographic + Clinicopathological data of the studied patients ( Table 1 ).
The clinic-pathological data of primary gastric lymphoma patients (Table1)

Analysis of Micro satellite Instability (MSI):
The result of MSI before and after helicobacter eradication therapy in all groups of primary gastric lymphoma ( Table 2) : The incidence of MSI at presentation in low grade MALT was 6/30 patients (20%), in patients with MALTDLBCL it was found in 16/36 patients (44%) and in those de novo DLBCL it was 15/41 patients (37%). The frequency of MSI in MALTDLBCL and de novo DLBCL was statistically significantly higher than in low grade MALT (P<0.05).
Reassessment of presence of MSI after helicobacter Pylori eradication therapy showed significant decrease of its incidence in all groups. In patients with low grade MALT the incidence of MSI decreased from (6/30 to 0/30 (P<0.001), All these patients achieved complete remission after helicobacter eradication. In patients with MALTDLBCL the frequency of MSI decreased from (16/36 to 2/36, P<0.001), all 14 patients who achieved complete remission had no evidence of MSI and the two patients were non responders to helicobacter eradication. In those with de novo DLBCL the frequency of MSI decreased from (15/41 to 5/41, P<0.01), three patients of them achieved complete remission after helicobacter eradication therapy; while remaining seven patients showed complete remission post chemotherapy.
In analysis of microsatellite marker, there was statistically significant increase incidence in D5S346, D9S171 and D17S250 in patients with de novo DLBCL and MALTDLBCL in comparison to those with low grade MALT. In D3S1530 it was significantly higher in MALTDLBCL in comparison to low grade MALT ( Figure 2 ).
Tumor response
Assessment of response at 6 weeks post completing anti-HP treatment course showed 90% complete histological remission (CR) in patients with low-grade MALT disease (27/30 patients), the remaining 3 patients did not respond to eradication therapy. In MALTDLBCL group the complete response rate (CR) was achieved in 25/36 patients (69%) and 11 patients did not respond to Helicobacter pylori eradication. In the de novo DLBCL 3/41 (7%) responded to helicobacter eradication while the majority 93% (38 patients) not respond to Helicobacter pylori eradication. The response to Helicobacter pylori treatment was significantly higher in Low grade MALT lymphoma group compared to MALTDLBCL and de novo DLBCL patients (p<0.05, p<0.001) respectively.
The relation of response rate to Helicobacter Pylori eradication therapy to degree of mucosal invasion was another interesting finding. In the low grade MALT type all complete responders had disease limited to mucosa and submucosa only, while in MALTDLBCL two patients of the complete responders had disease invasion to muscularis propria. In de novo DLBCL, the only 3 patients who responded to Helicobacter pylori eradication had the invasion depth limited to mucosa and submucosa only. (Table 3) Response of primary gastric lymphoma patients to chemotherapy (Table 3) : Patients who did not achieve CR after helicobacter eradication therapy referred to systemic chemotherapy (Anthracyclin based chemotherapy). 3 patients of Low grade MALT received chemotherapy and achieved CR after 4 cycle of chemotherapy. 11 patients of MALTDLBCL lymphoma received CHOP and achieved CR post chemotherapy, 9 of them after 3 cycles and others 2 patients after 6 cycles. 38 patients of de novo DLBCL received anthracyclinbased chemotherapy (CHOP), 32 patients achieved CR after 3 cycle and others 6 after 6 cycles of chemotherapy.
Response of primary gastric lymphoma patients post helicobacter pylori eradication
Discussion
To the best of our knowledge, this is the first study evaluating the alteration in MSI level in primary gastric lymphoma before and after Helicobacter Pylori eradication with long term follow up (1999 -2004) We clearly found 1) The incidence of MSI at diagnosis significantly increases from low grade MALT gastric lymphoma to DLBCL gastric lymphoma, 2) The incidence of MSI significantly decrease post helicobacter pylori eradication therapy and is significantly correlated with histological remission, 3) Chemotherapy in cases of failure to respond to anti HP therapy contributed to complete response in De-Novo DLBCL gastric lymphoma.
MSI is a mutation phenotype that occurs through defect in DNA mismatch repair system and contributes in cancer development [28] . Our results showed that incidence of MSI significantly increases as the histological subtype progress from low grade gastric MALT to MALTDLBCL and DLBCL which express that MSI plays an important contributory role in transformation to high grade disease. This finding supports previous reports about the role of MSI in lymphogenesis [3, 18, 19, 20] There are a few explanations about the difference in incidence of MSI between our study and these reports. First, the choice of genetic loci for MSI analysis, we analyzed markers adjacent to chromosomal loci that are involved in lymphomas, 'Real Common Target genes theory' [3, 18] . Second, method of analysis micro satellite instability, our analysis was based on gel electrophoresis which is the most accurate method [3, 29] . The incidence of instability in locus differs in studied subjects depending on the genetic background of people and geographic regions [30, 31] .
Many studies reported that the change in the molecular behavior in patients post eradication of Helicobacter pylori have an important impact in decreased incidence of carcinogensis [32] [33] [34] [35] . Our result showed significant change in molecular behavior by reversion in the DNA damage (MSI) post Helicobacter Pylori eradication and that associated with histological remission of primary gastric lymphoma, which clarify the importance of the role of helicobacter eradication treatment not only in low grade MALT lymphoma but also in DLBCL gastric lymphoma (with and without MALT components). Eradication of helicobacter pylori release cell from inflammatory toxic effect and restore normal function expression of the cell [25] .
Several studies have shown that Helicobacter pylori eradication results in durable histological complete remission in patients with gastric DLBCL (with and without MALT Component) [9] [10] [11] [12] [13] [14] [15] 16] . In agreement with previous reports, our result showed the complete response rate (CR) in MALTDLBCL to helicobacter eradication therapy was 69%, and in de novo DLBCL was 7%. No significance difference among all group in overall survival after helicobacter eradication support the previous conclusion that loss of helicobacter dependence and high grade transformation are two separate events [16, 38] .
Another interesting finding was that complete response to helicobacter eradication therapy significantly correlated with the depth of tumor invasion depth in all histological subtypes of gastric lymphoma as previously reported [9, 16, 35, 36] .
Other studies reported the efficacy of (chemotherapy) as compared to surgery in treatment of gastric lymphoma specially DLBCL gastric lymphoma [35, 37, 39] . In our study we clarify that patients who did not achieve CR post Helicobacter eradication had a very good response to chemotherapy and achieved very rapid CR response with no significance difference in overall survival between MALT and non MALT gastric lymphoma, this phenomenon can be explained by the fact that eradication of helicobacter retain the biological behavior of cells (e.g., responsiveness to lymphocyte-activating cytokines such as tumor necrosis factor , interleukin [IL]-which may be contributed to excellent result chemotherapy [13, 37] and also with correction of genetic errors on cell such as microsatellite instability as we may be also contribute for good response and rapid remission rate by prevention of DNA error replication which lead to cut the antigenic pathway stimulation of gastric lymphoma.
In conclusion, microsatellite insatiability (MSI) plays an important role in development of primary gastric lymphoma mainly in DLBCL types. Our result confirmed the role of Helicobacter pylori eradication in controlling primary gastric lymphoma and its effect in correction of MSI. We recommend addition of Helicobacter Pylori eradicating therapy to all newly diagnosed cases of HP associated gastric lymphomas and especially to DLBCL type. 
